Thermo Fisher Scientific Reports 9% Revenue Growth as Third-Quarter Earnings Beat Estimates
Thermo Fisher Scientific (NYSE:TMO) reported third-quarter 2026 earnings and revenue above analysts’ expectations on Wednesday, supported by growth in its laboratory products and services business and an improvement in operating margins. The US life sciences and laboratory equipment company posted adjusted earnings per share of $6.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Yahoo